WD-890

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameWD-890
Drug Alias NameWD-890WD890
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPlaque psoriasisPsoriasisLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNingbo Wenda Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNingbo Wenda Pharma
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A